E.E.S 400 (erythromycin ethylsuccinate) NDC 24338-100

NDC codes

FDA NDC Directory

Product NDC (as listed)24338-100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24338-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24338-100-03	24338010003	30 TABLET in 1 BOTTLE (24338-100-03)Marketed from Jun 28, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): E.E.S 400Suffix: 400
Generic name (nonproprietary): erythromycin ethylsuccinate
Active ingredients: Erythromycin ethylsuccinate — 400 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 061905
Marketing start: May 3, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 24338-100_0ca69356-c906-e9a9-e063-6394a90a9395SPL ID 0ca69356-c906-e9a9-e063-6394a90a9395SPL set ID b455bbdb-a3f1-470f-aa5f-ed83ac2e228dRxCUI 686400, 686405, 863603, 863606UNII 1014KSJ86FUPC 0300746302131, 0324338100035
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424338010003 followed by a unit qualifier and the quantity

Package 24338-0100-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of E.E.S. and other antibacterial drugs, E.E.S. should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. E.E.S. is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: Upper respiratory …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 061905

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 061905
Product	Strength	Form · route	Labeler	Product NDC
E.E.S 400erythromycin ethylsuccinate	Erythromycin ethylsuccinate 400 mg/1	TabletOral	REMEDYREPACK INC.	70518-4681